论文部分内容阅读
戴同志所提的意见,本刊曾转告方正规同志,并得到他的答复。他认为,磺胺嘧啶钠及去甲肾上腺素与静脉输液合併滴注,的确存在着配伍禁忌的可能性,因此提出以引起临床的警惕是十分必要的。关于去甲肾上腺素在硷性液中减效的问题,方同志承认,原文对实验的观察只注意了理化禁忌,未注意到对疗效方面的影响,达也是原文的一个很大的缺点。他并且对戴同志及时提出这些意兄表示感谢。另外,本刊还收到了一篇由江苏省卫生干校附属医院药剂科孙银根和镇江专区医院药局张修政寄来的内容类似的意见。
With the comments made by my comrades, this magazine has conveyed to our legitimate comrades and received his reply. He believes that sulfadiazine sodium and norepinephrine infusion combined with intravenous infusion, there is indeed the possibility of incompatibility compatibility, it is proposed to arouse clinical vigilance is very necessary. Concerning the problem of norepinephrine in reducing alkaline fluid, Fang admitted that the original observation on the experiment only paid attention to physical and chemical taboos and failed to notice the effect on the curative effect. Tatsu also is a major shortcoming of the original text. He also thanked him for putting forward these suggestions in time. In addition, the publication also received an article by the Jiangsu Provincial Health School Affiliated Hospital Pharmacy Branch Sun Yingen and Zhenjiang District Hospital Bureau Zhang Xunzheng sent similar views.